San Diego biotech Evofem Biosciences, which focuses on women’s sexual and reproductive health, announced a public stock offering on May 22.
BIOTECH: From Cancer to Concussions, Efforts Change Cost, Course of Treatments
Banyan Biomarkers hit a milestone in February when its blood test for traumatic brain injuries won U.S. Food and Drug Administration approval.
San Diego’s AristaMD has hired Adam Darkins, known for his work with the Department of Veterans Affairs, as the company's chief strategy officer.
The Gary and Mary West Emergency Department at UC San Diego Health last week was accredited as a geriatric emergency department, the first such accreditation in California and one of only eight nationally.
San Diego-based Cidara Therapeutics and Rutgers University were awarded a $5.5 million grant to research and further develop an immunotherapy platform.
HEALTH: Drug Treats Seizures; Co. Prepares For Commercialization
A plant-derived cannabis medicine is poised to be the first of its kind to win U.S. Food and Drug Administration approval. A winner of the expected greenlight: Carlsbad’s Greenwich Biosciences.
PHARMA: Co. Transforms After Weight-Loss Flop
Arena Pharmaceuticals’ weight-loss drug flopped a few years ago, signaling a bleak future. That is, if you ignored Arena’s shelved compounds.
Accelerator Life Science Partners, a life science investment and management firm, has opened a San Diego office at The Alexandria at Torrey Pines.
Former film executive Sherry Lansing, who led Paramount and Fox motion picture studios, has been named to The Scripps Research Institute board.
BIOTECH: Acquisition Moves Co. Toward Push-Button Process for Analysis
Illumina bought data processing specialist Edico Genome for $100 million as part of a bid to expand genomics testing in research and health care.